Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe record history now lists a new revision (v3.6.5) that supersedes the previous version (v3.6.4).SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history now shows a new entry for Revision: v3.6.4, updating the page's revision metadata from v3.6.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe record history now includes a new version entry for v3.6.3 and removes the previous v3.6.2 entry, signaling an updated revision of the study record. This update documents the latest revision in the history.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed. This reflects an update to the documentation of the page's history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe record history now shows explicit 'Last verified' and 'Last known status was' with a new 'Revision: v3.6.0', replacing the previous labels and the older revision 'v3.5.5'.SummaryDifference3%

- Check66 days agoChange DetectedThe study history shows a new revision entry (v3.5.5) and the previous revision (v3.5.4) is removed from the history list, updating the visible record of changes.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.